Moleculin Biotech
MBRX
MBRX
22 hedge funds and large institutions have $925K invested in Moleculin Biotech in 2023 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 5 reducing their positions, and 3 closing their positions.
Holders
22
Holders Change
–
Holders Change %
0%
% of All Funds
0.35%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
3
Reduced
5
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
1
Squarepoint
New York
|
$0 |
| 2 |
SCM
2
Sio Capital Management
New York
|
$116K |
| 3 |
TSS
3
Two Sigma Securities
New York
|
$0 |
| 4 |
4
Renaissance Technologies
New York
|
$51K |
| 5 |
5
Millennium Management
New York
|
$13K |
